Intelligent Blood Treatment System with Synergistic Combinations

The present inventive concept integrates a blood treatment apparatus with distinct technologies such as AI, IoT, blockchain, and new materials to create a more powerful system, enabling personalized treatment recommendations, real-time feedback, and secure data management.

The original patent disclosed a method for setting a control device or a closed-loop control device of a blood treatment apparatus. However, this method had limitations in terms of data analysis, security, and personalized treatment. The new inventive concept addresses these limitations by incorporating synergistic combinations of technologies to enhance the blood treatment apparatus.

The new inventive concept comprises a blood treatment apparatus integrated with an AI-powered predictive analytics module, a blockchain-based decentralized data storage system, an IoT-enabled sensor network, and a machine learning-based decision support system. The AI module analyzes treatment data and provides personalized treatment recommendations to a user. The blockchain system securely stores and shares treatment data among healthcare providers and patients. The IoT sensor network monitors treatment parameters and provides real-time feedback to the blood treatment apparatus. The machine learning-based decision support system analyzes treatment data and provides personalized treatment recommendations. Additionally, the blood treatment apparatus incorporates a new material with enhanced biocompatibility and durability.

The new claims introduce a synergistic combination of technologies that creates a more powerful system, enabling personalized treatment recommendations, real-time feedback, and secure data management. The integration of AI, IoT, blockchain, and new materials with the blood treatment apparatus is novel and non-obvious compared to the original patent.

Alternative embodiments of the inventive concept could include integrating the blood treatment apparatus with other technologies such as augmented reality, 5G networks, or advanced biomaterials. Variations of the inventive concept could include adapting the system for use in different medical applications or integrating it with existing healthcare infrastructure.

The intelligent blood treatment system has significant commercial potential in the healthcare industry, particularly in the areas of personalized medicine, medical device development, and healthcare data management. The target market includes hospitals, clinics, and medical research institutions.